LHC Group, Inc. (NASDAQ:LHCG) Shares Purchased by Swiss National Bank

Swiss National Bank increased its position in shares of LHC Group, Inc. (NASDAQ:LHCG) by 0.5% in the 3rd quarter, Holdings Channel.com reports. The firm owned 66,466 shares of the health services provider’s stock after acquiring an additional 300 shares during the quarter. Swiss National Bank’s holdings in LHC Group were worth $10,429,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in LHCG. Moors & Cabot Inc. acquired a new stake in LHC Group during the third quarter worth about $25,000. Liberty Wealth Management LLC increased its position in LHC Group by 21,038.9% during the second quarter. Liberty Wealth Management LLC now owns 11,415 shares of the health services provider’s stock worth $57,000 after purchasing an additional 11,361 shares during the last quarter. Eubel Brady & Suttman Asset Management Inc. acquired a new stake in LHC Group during the second quarter worth about $57,000. Heritage Wealth Management LLC increased its position in LHC Group by 55.1% during the second quarter. Heritage Wealth Management LLC now owns 307 shares of the health services provider’s stock worth $61,000 after purchasing an additional 109 shares during the last quarter. Finally, Van ECK Associates Corp acquired a new stake in LHC Group during the second quarter worth about $74,000. Hedge funds and other institutional investors own 93.35% of the company’s stock.

In related news, EVP Nicholas Gachassin III sold 800 shares of LHC Group stock in a transaction that occurred on Thursday, December 16th. The shares were sold at an average price of $125.25, for a total value of $100,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 4.80% of the stock is owned by insiders.

NASDAQ LHCG opened at $131.42 on Friday. The firm has a 50 day simple moving average of $132.03 and a 200-day simple moving average of $163.27. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.02 and a current ratio of 1.02. LHC Group, Inc. has a one year low of $108.42 and a one year high of $223.80. The firm has a market cap of $4.16 billion, a price-to-earnings ratio of 31.67, a PEG ratio of 1.66 and a beta of 0.37.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, November 3rd. The health services provider reported $1.45 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.45. LHC Group had a net margin of 6.01% and a return on equity of 11.07%. The business had revenue of $565.45 million during the quarter, compared to analyst estimates of $565.30 million. During the same quarter last year, the firm posted $1.63 earnings per share. Equities analysts predict that LHC Group, Inc. will post 5.78 EPS for the current fiscal year.

LHCG has been the subject of a number of recent analyst reports. Credit Suisse Group dropped their price target on shares of LHC Group from $191.00 to $184.00 and set an “outperform” rating for the company in a research report on Friday, November 5th. Truist Securities dropped their price target on shares of LHC Group from $240.00 to $185.00 and set a “buy” rating for the company in a research report on Wednesday, October 13th. Truist dropped their price target on shares of LHC Group from $240.00 to $185.00 and set a “buy” rating for the company in a research report on Wednesday, October 13th. UBS Group initiated coverage on shares of LHC Group in a research report on Thursday, September 23rd. They set a “neutral” rating and a $170.00 price target for the company. Finally, Zacks Investment Research upgraded shares of LHC Group from a “strong sell” rating to a “hold” rating and set a $136.00 price target for the company in a research report on Monday, December 20th. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $173.82.

LHC Group Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Read More: Profit margin is different from the revenue

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.